Moneycontrol
HomeNewsIndiaCentre moves SC seeking extension of time for framing guidelines for ex-gratia
Trending Topics

Centre moves SC seeking extension of time for framing guidelines for ex-gratia

The Centre in an application said that the exercise which was in active consideration of the NDMA was at an advance stage and requires a little more in-depth examination.

July 20, 2021 / 20:10 IST
Story continues below Advertisement

The Centre has moved the Supreme Court seeking extension of time granted by the apex court to the National Disaster Management Authority (NDMA) to frame guidelines for ex-gratia compensation to families of those who died of COVID-19 by another four weeks.

The apex court had in its June 30 verdict directed NDMA to recommend within six weeks appropriate guidelines for ex-gratia assistance on account of loss of life to the family members of persons who died due to COVID-19.

Story continues below Advertisement

The Centre in an application said that the exercise which was in active consideration of the NDMA was at an advance stage and requires a little more in-depth examination.

Applicant (Union of India) respectfully submits that exercise to frame appropriate guidelines for payment of ex-gratia payment to the victims of COVID-19 disaster under section 12 (iii) of the DMA (Disaster Management Act) is in active consideration of the NDMA and going on, said the plea, drawn by advocate Rajat Nair.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show